CADRe

Defining the critical components of informed consent for genetic testing.
The Clinical Genome Resource (ClinGen) Consent and Disclosure Recommendations Workgroup (CADRe) used an expert consensus process to identify the core concepts essential to consent for clinical genetic testing.
Cite DOI
Defining the critical components of informed consent for genetic testing.
CADRe workgroup
The Consent and Disclosure Recommendations (CADRe) workgroup developed an ethical framework for consent and disclosure of genetic testing. The aim of this work is to improve access to genetic testing by supporting non-genetics trained healthcare providers to facilitate genetic testing.
CADRe workgroup
Application of a framework to guide genetic testing communication across clinical indications
The CADRe recommendations provide guidance for clinicians in determining the depth of pre- and post-test communication, strategically aligning the anticipated needs of patients with the starting communication approach
Cite DOI
Application of a framework to guide genetic testing communication across clinical indications
Genetic Testing: Consent and Result Disclosure for Primary Care Providers.
This article provides guidance about the recommended level of involvement of PCPs based on the test indication, test complexity, disorder management, and the potential for psychosocial sequela.
Cite DOI
Genetic Testing: Consent and Result Disclosure for Primary Care Providers.
Developing a conceptual, reproducible, rubric-based approach to consent and result disclosure for genetic testing by clinicians with minimal genetics background.
Considering ethical, legal, and social implications, and medical factors, CADRe developed and pilot tested two rubrics addressing consent for genetic testing and results disclosure.
Cite DOI
Developing a conceptual, reproducible, rubric-based approach to consent and result disclosure for genetic testing by clinicians with minimal genetics background.